Mark Brody
Impact in
- Physiology top 0.5%
- Alzheimer's disease research and treatments
- Psychiatry and Mental health top 2%
- Dementia and Cognitive Impairment Research
Papers in
- Physiology 19
- Alzheimer's disease research and treatments 19
- Genetics 4
- Mesenchymal stem cell research 4
- Co-authors
- Christopher H. van Dyck (3 shared papers)Craig T Curtis (3 shared papers)Robert H. Paul (1 shared paper)Christina Rabe (1 shared paper)David Clayton (1 shared paper)Deborah L. Mortensen (1 shared paper)Reina N. Fuji (1 shared paper)Sharon Cohen (1 shared paper)
- Journals
- Alzheimer s & Dementia (10 papers)Neurology (3 papers)JAMA Neurology (2 papers)JAMA (2 papers)Journal of Alzheimer s Disease (1 paper)
- Partner nations
- United StatesSwedenIreland
In The Last Decade
Mark Brody
21 papers receiving 3k citations
Mark Brody's Hit Papers
Peers
Comparison fields: 5 of 92
- Physiology 2k
- Psychiatry and Mental health 996
- Neurology 155
- Neurology 115
- Developmental Neuroscience 18
Countries citing papers authored by Mark Brody
This map shows the geographic impact of Mark Brody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Brody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Brody more than expected).
Fields of papers citing papers by Mark Brody
This network shows the impact of papers produced by Mark Brody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Brody. The network helps show where Mark Brody may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Brody, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Donanemab in Early Symptomatic Alzheimer Disease Hit paper breakdown → | 2023 | 1799 |
| 2 | 2012 | 329 | |
| 3 | 2015 | 212 | |
| 4 | 2018 | 208 | |
| 5 | Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease Hit paper breakdown → | 2022 | 156 |
| 6 | 2021 | 104 | |
| 7 | 2023 | 79 | |
| 8 | 2022 | 54 | |
| 9 | 2018 | 34 | |
| 10 | Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer’s disease: a randomized controlled phase 2a trial Hit paper breakdown → | 2025 | 34 |
| 11 | 2016 | 29 | |
| 12 | 2013 | 9 | |
| 13 | 2021 | 7 | |
| 14 | 2011 | 4 | |
| 15 | 2009 | 2 | |
| 16 | 2024 | 2 | |
| 17 | 2011 | 1 | |
| 18 | 2016 | 1 | |
| 19 | 2019 | 1 | |
| 20 | 2020 | 1 |
About Mark Brody
Mark Brody is a scholar working on Physiology, Genetics, Psychiatry and Mental health, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 22 papers that have together received 3.1k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (19 papers), Dementia and Cognitive Impairment Research (4 papers) and Mesenchymal stem cell research (4 papers). The work is most often cited by research in Physiology (2k citations), Psychiatry and Mental health (996 citations), Neurology (155 citations), Neurology (115 citations) and Developmental Neuroscience (18 citations). Mark Brody has collaborated with scholars based in United States, Sweden and Ireland. Frequent co-authors include Christopher H. van Dyck, Craig T Curtis, Robert H. Paul, Christina Rabe, David Clayton, Deborah L. Mortensen, Reina N. Fuji, Sharon Cohen, Jeffrey L. Cummings and Michael Emmerson Ward. Their work appears in journals such as Alzheimer s & Dementia, Neurology, JAMA Neurology, JAMA and Journal of Alzheimer s Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.